Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

High school basketball: Scores for boys’ and girls’ games across the Southland on Wednesday, Feb. 12. High school basketball: Scores for boys’ and girls’ games across the Southland on ...

Police work in an area around the Clemenceau metro station after a shooting incident in Brussels, Wednesday, Feb. 5, 2025. (AP Photo/Sylvain Plazy) ...

As a trans person, I have avoided writing about sports because it only distracts from infinitely larger issues, such as access to healthcare, bodily autonomy and equal protection.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Welcome to your Tuesday edition of Brussels Playbook, where we cannot unhear French President Emmanuel Macron saying “plug, baby, plug,” and we cannot unsee this AI-generated … February 11, 2025 14 ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...

Check sunscreens for those that are noncomedogenic. Heavy application of moisturizers and sunscreen can potentially block sweat glands and cause the formation of a rash called miliaria, which may be ...